Cerebral hemodynamics during treatment with sodium nitroprusside versus labetalol in malignant hypertension

Hypertension

Volumn 52, Issue 2, 2008, Pages 236-240

  Immink, Rogier V ^a,c   Van Den Born, Bert Jan H ^b   Van Montfrans, Gert A ^b   Kim, Yu Sok ^b,c   Hollmann, Markus W ^a   Van Lieshout, Johannes J ^b,c,d  

^a Department of Anesthesiology ^*

^b Internal and Vascular Medicine

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cardiovascular disease stroke; Cardiovascular pharmacology; Doppler ultrasound; Other hypertension; Transcranial doppler

Indexed keywords

LABETALOL; NITROPRUSSIDE SODIUM; ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN VASCULAR RESISTANCE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG DOSE INCREASE; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; MALE; MALIGNANT HYPERTENSION; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; SYSTEMIC CIRCULATION; SYSTEMIC VASCULAR RESISTANCE; ANALYSIS OF VARIANCE; BLOOD PRESSURE MEASUREMENT; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; ELECTROCARDIOGRAPHY; FOLLOW UP; HEMODYNAMICS; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; NONPARAMETRIC TEST; PHYSIOLOGY; PROBABILITY; PROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ADULT; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CEREBROVASCULAR CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEMODYNAMICS; HUMANS; HYPERTENSION, MALIGNANT; INFUSIONS, INTRAVENOUS; LABETALOL; MALE; MIDDLE AGED; NITROPRUSSIDE; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASCULAR RESISTANCE;

EID: 49849094916     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.110395     Document Type: Article

References (35)

1. Immink RV, van den Born BJ, Van Montfrans GA, Koopmans RP, Karemaker JM, Van Lieshout JJ. Impaired cerebral autoregulation in patients with malignant hypertension. Circulation. 2004;110:2241-2245.
2. Lipsitz LA, Mukai S, Hamner J, Gagnon M, Babikian V. Dynamic regulation of middle cerebral artery blood flow velocity in aging and hypertension. Stroke. 2000;31:1897-1903.
3. Strandgaard S, MacKenzie ET, Sengupta D, Rowan JO, Lassen NA, Harper AM. Upper limit of autoregulation of cerebral blood flow in the baboon. Circ Res. 1974;34:435-440.
4. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;118:214-227.
5. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356: 411-417.
6. Feldstein C. Management of hypertensive crises. Am J Ther. 2007;14: 135-139.
7. Kaplan NM. Hypertensive crises. In: Kaplan NM, ed. Clinical Hypertension. Baltimore, MD: Williams Wilkins; 1998:265-280.
8. Calhoun DA, Oparil S. Treatment of hypertensive crisis. N Engl J Med. 1990;323:1177-1183.
9. Gifford RW Jr. Management of hypertensive crises. JAMA. 1991;266: 829-835.
10. Anile C, Zanghi F, Bracali A, Maira G, Rossi GF. Sodium nitroprusside and intracranial pressure. Acta Neurochir (Wien). 1981;58:203-211.
11. Simsic JM, Bradley SM, Mulvihill DM. Sodium nitroprusside infusion after bidirectional superior cavopulmonary connection: preserved cerebral blood flow velocity and systemic oxygenation. J Thorac Cardiovasc Surg. 2003;126:186-190.
12. Vesey CJ, Cole PV, Simpson PJ. Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man. Br J Anaesth. 1976;48: 651-660.
13. Kanto J, Allonen H, Kleimola T, Mantyla R. Pharmacokinetics of labetalol in healthy volunteers. Int J Clin Pharmacol Ther Toxicol. 1981; 19:41-44.
14. Ahearn DJ, Grim CE. Treatment of malignant hypertension with sodium nitroprusside. Arch Intern Med. 1974;133:187-191.
15. Wilson DJ, Wallin JD, Vlactiakis ND, Preis ED, Vidt DG, Michelson EL, Langford HG, Flamenbaum W, Poland MP. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies. Am J Med. 1983;75:95-102.
16. Wesseling KH, Jansen JRC, Settels JJ, Schreuder JJ. Computation of aortic flow from pressure in humans using a nonlinear, three-element model. J Appl Physiol. 1993;74:2566-2573.
17. Jellema WT, Wesseling KH, Groeneveld AB, Stoutenbeek CP, Thijs LG, Van Lieshout JJ. Continuous cardiac output in septic shock by simulating a model of the aortic input impedance: a comparison with bolus injection thermodilution. Anesthesiology. 1999;90:1317-1328.
18. Jansen JRC, Schreuder JJ, Mulier JP, Smith NT, Settels JJ, Wesseling KH. A comparison of cardiac output derived from the arterial pressure wave against thermodilution in cardiac surgery patients. Br J Anaesth. 2001;87:212-222.
19. Harms MPM, Wesseling KH, Pott F, Jenstrup M, Van Goudoever J, Secher NH, Van Lieshout JJ. Continuous stroke volume monitoring by modelling flow from non-invasive measurement of arterial pressure in humans under orthostatic stress. Clin Sci (Lond). 1999;97:291-301.
20. Zhang R, Crandall CG, Levine BD. Cerebral hemodynamics during the Valsalva maneuver. Insights from ganglionic blockade. Stroke. 2004;35: 843-847.
21. Bishop CC, Powell S, Rutt D, Browse NL. Transcranial Doppler measurement of middle cerebral artery blood flow velocity: a validation study. Stroke. 1986;17:913-915.
22. Immink RV, Van Montfrans GA, Stam J, Karemaker JM, Diamant M, Van Lieshout JJ. Dynamic cerebral autoregulation in acute lacunar and middle cerebral artery territory ischemic stroke. Stroke. 2005;36:2595-2600.
23. Chiariello M, Gold HK, Leinbach RC, Davis MA, Maroko PR. Comparison between the effects of nitroprusside and nitroglycerin on ischemic injury during acute myocardial infarction. Circulation. 1976;54:766-773.
24. Mann T, Cohn PF, Holman LB, Green LH, Markis JE, Phillips DA. Effect of nitroprusside on regional myocardial blood flow in coronary artery disease. Results in 25 patients and comparison with nitroglycerin. Circulation. 1978;57:732-738.
25. Tiecks FP, Lam AM, Aaslid R, Newell DW. Comparison of static and dynamic cerebral autoregulation measurements. Stroke. 1995;26:1014-1019.
26. Aaslid R, Lindegaard KF, Sorteberg W, Nomes H. Cerebral autoregulation dynamics in humans. Stroke. 1989;20:45-52.
27. Panerai RB, Dawson SL, Potter IF. Linear and nonlinear analysis of human dynamic cerebral autoregulation. Am J Physiol Heart Circ Physiol. 1999;277:H1089-H1099.
28. Lavi S, Egbarya R, Lavi R, Jacob G. Role of nitric oxide in the regulation of cerebral blood flow in humans: chemoregulation versos mechanoregulauon. Circulation. 2003;107:1901-1905.
29. Olsen KS, Svendsen LB, Larsen FS, Paulson OB. Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth. 1995;75:51-54.
30. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev. 1959;39:183-238.
31. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. 1996;27:144-147.
32. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation. 1976;53:720-727.
33. Strandgaard S, Jones JV, MacKenzie ET, Harper AM. Upper limit of cerebral blood flow autoregulation in experimental renovascular hypertension in the baboon. Circ Res. 1975;37:164-167.
34. Giller CA, Bowman G, Dyer H, Mootz L, Krippner W. Cerebral arterial diameters during changes in blood pressure and carbon dioxide during craniotomy. Neurosurgery. 1993;32:737-741.
35. Serrador JM, Picot PA, Run BK, Shoemaker JK, Bondar RL. MRI measures of middle cerebral artery diameter in conscious humans during simulated orthostasis. Stroke. 2000;31:1672-1678.